Showing results (1-10 of 81) with videos related to
Sort By:
Pageof 9
Journal of Intensive Care Medicine|August 7, 2004
Acute respiratory failure from abused substancesKevin C Wilson, Jussi J SaukkonenClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 23, 2020
Community-acquired Pneumonia Guideline Recommendations-Impact of a Consensus-based Process versus Systematic ReviewsKevin C Wilson, Noah C Schoenberg, David L Cohn, et al.Infection and Immunity|March 16, 2002
Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growthJussi J Saukkonen, Beth Bazydlo, Michael Thomas, et al.American Journal of Respiratory and Critical Care Medicine|July 1, 2006
Predicting non-completion of treatment for latent tuberculous infection: a prospective surveyFred K Shieh, Graham Snyder, C Robert Horsburgh, et al.Current Opinion in Pulmonary Medicine|February 19, 2021
Coronavirus disease 2019 managementKevin C WilsonAmerican Journal of Respiratory and Critical Care Medicine|October 13, 2004
Recurrent tuberculosis in the United States and Canada: relapse or reinfection?Robert M Jasmer, Lorna Bozeman, Kevin Schwartzman, et al.American Journal of Respiratory and Critical Care Medicine|January 18, 2011
An appraisal of the evidence underlying performance measures for community-acquired pneumoniaKevin C Wilson, Holger J SchünemannAnnals of the American Thoracic Society|December 6, 2024
Noninvasive Ventilation in Acute Asthma Exacerbations: A Systematic ReviewCollin Homer-Bouthiette, Kevin C WilsonClinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 17, 2004
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a cost-effectiveness analysis based on a multicenter clinical trialRobert M Jasmer, David C Snyder, Jussi J Saukkonen, et al.Annals of Internal Medicine|October 16, 2002
Short-course rifampin and pyrazinamide compared with isoniazid for latent tuberculosis infection: a multicenter clinical trialRobert M Jasmer, Jussi J Saukkonen, Henry M Blumberg, et al.Pageof 9